An alarming number of infectious diseases are becoming increasingly difficult to treat with existing antibacterial drugs. This is due primarily to the rate at which bacteria becomes resistant to standard antibiotics. As a result there is a growing concern that an 'antibiotic crisis' is looming.
CSIRO scientists have identified and patented a new antibacterial drug target named 'Beta' that may address this problem.
This was followed by the development of an assay that helps researchers identify molecules that interfere with the normal function of Beta.
These new drug candidates offer a starting point for researchers and industry to develop new classes of antibiotics with improved resistance profiles.
0 comments:
Post a Comment